SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-008545
Filing Date
2017-11-08
Accepted
2017-11-08 16:16:14
Documents
47
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q axsm-20170930x10q.htm 10-Q 1254512
2 EX-31.1 axsm-20170930ex31139f2de.htm EX-31.1 11966
3 EX-31.2 axsm-20170930ex312bfa8b3.htm EX-31.2 11202
4 EX-32.1 axsm-20170930ex321830d03.htm EX-32.1 5909
5 EX-32.2 axsm-20170930ex3222ed32e.htm EX-32.2 5894
  Complete submission text file 0001558370-17-008545.txt   3466391

Data Files

Seq Description Document Type Size
6 EX-101.INS axsm-20170930.xml EX-101.INS 569195
7 EX-101.SCH axsm-20170930.xsd EX-101.SCH 24987
8 EX-101.CAL axsm-20170930_cal.xml EX-101.CAL 29088
9 EX-101.DEF axsm-20170930_def.xml EX-101.DEF 52660
10 EX-101.LAB axsm-20170930_lab.xml EX-101.LAB 232106
11 EX-101.PRE axsm-20170930_pre.xml EX-101.PRE 160722
Mailing Address 25 BROADWAY, 9TH FLOOR NEW YORK NY 10004
Business Address 25 BROADWAY, 9TH FLOOR NEW YORK NY 10004 212-203-5072
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

IRS No.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37635 | Film No.: 171186808
SIC: 2834 Pharmaceutical Preparations